PRGO Breakdown

PRGO Swing Trade Playbook (Nov 2026)

PRGO (Perrigo Company) – Healthcare name showing pre-breakout behavior. Trading near key support levels with constructive momentum in the consumer healthcare sector.

📈 View PRGO on TradingView

Trade Scenarios

Scenario Entry Zone Stop Loss Target 1 Target 2 Risk-Reward
(to T1 / T2)		 Est. Win Prob. Potential Return
(to T1)		 Max Loss
Conservative
(Pullback)		 \$26.80 – \$27.40 \$25.90 \$29.80 \$31.50 – \$32.50 1:3.1 / 1:5+ 50–55% +9–11% −4–5%
Moderate
(Momentum)		 \$27.50 – \$28.00 \$26.50 \$30.20 \$32.00 – \$33.00 1:2.6 / 1:4.8 45–50% +8–9% −4.5–5%
Aggressive
(Breakout)		 \$28.30+ \$27.20 \$30.80 \$33.50+ 1:2.1 / 1:4.5 40–45% +8–9% −5%

Risk Rules: Risk no more than 1% of account per trade. Trail stops once Target 1 is reached. Use ATR for dynamic adjustments.

Technical & Sentiment Overview

  • Key Support: \$26.80–27.40, \$25.90, \$24.50
  • Key Resistance: \$28.30, \$29.80–30.20, \$31.50–33.00
  • Indicators: RSI mid-60s, price near moving average support, improving relative strength
  • Fundamentals: Consumer healthcare and generic pharmaceuticals with stable cash flow
  • Sentiment: Defensive healthcare exposure supporting interest

Key Risks

Generic drug pricing pressure, regulatory risk, and competition in OTC healthcare products.

Disclaimer: This post is for educational and informational purposes only and does not constitute financial, investment, or trading advice. Trading stocks and options involves substantial risk of loss and is not suitable for all investors. Past performance is not indicative of future results. The information presented is believed to be accurate but is not guaranteed. Always conduct your own due diligence and consult a qualified financial advisor before making any investment decisions. Market conditions can change rapidly. The author may or may not hold positions in the securities discussed.

Comments

Post a Comment

Popular posts from this blog

X Accounts Traders To Follow

Navigating the Wild World of Trading Twitter: 14 Accounts Worth Watching in 2026 The trading scene on X (formerly Twitter) is chaotic—hype, real-time alerts, massive wins (and wipeouts). These accounts span penny stock momentum chasers, day traders, community builders, and macro news giants. Always DYOR: these are opinions only, high-risk space! Penny/Momentum Runner Spotters (High-Risk, High-Reward) These accounts flag low-float, volatile small-caps that can explode 100–400%+ in a session (e.g., recent $QNCX, $RENX runners). @Boytrader08 (~7k followers): Daytrader posting after-hours penny action, quick ideas/recaps on movers like $RENX, $AREB. @stomping_llama (~5.5k): "Trash penny stocks" skeptic—shorts, DD, anti-hype angles (e-book/blog links). @Mitch___Picks (~88k): 15+ years penny/crypto/options experience; casual takes, watchlists, modest engagement. @BeforeTheRocket (~13k): Parabolic swing ideas, "before they run...
Read more

ALLO

Swing Trade Playbook: ALLO for Monday, July 28, 2025 Disclaimer This swing trade playbook is crafted by @shaneman007 with assistance from Grok, an AI developed by xAI, using data as of August 28, 2025. Grok aims to provide accurate insights but may make errors. Trading is high-risk; conduct your own research and consult a financial advisor before acting. Past performance does not guarantee future results. Swing Trade Playbook: Allogene Therapeutics (ALLO) for Monday, July 28, 2025 Hey, swing traders! It’s @shaneman007, dropping a hot playbook for Allogene Therapeutics (ALLO) , a biotech penny stock primed for action. If you’re chasing 30–60% returns over 1–3 days like me, ALLO’s momentum and short-squeeze potential make it a must-watch for Monday, July 28, 2025. With Grok’s number-crunching, I’ve got a clear plan to help you score big while keeping risk tight. Let’s roll! Market Vibe: What’s the Buzz? ...
Read more

IXHL 🎰 Pack Your Moon Bags?

IXHL: A Simple “Lottery-Ticket” Roadmap (Not Financial Advice) IXHL: A Simple “Lottery-Ticket” Roadmap Here’s a straightforward and realistic speculative scenario map for IXHL based on historical trading behavior, current setup, and upcoming catalysts. These are scenarios only , not predictions — IXHL is a volatile micro-cap biotech at the $0.40 level, and movements tend to be extreme both directions. Scenario Breakdown Scenario Entry Zone First Target Stretch Target % Gain Time Frame Probability Trigger Quick Scalp / Oversold Bounce $0.39 – $0.42 $0.52 – $0.58 $0.65 +25% → +58% 1–10 days High (70%) Volume + short covering News Pop (trial update, partnership rumor, FDA notes) $0.40 – $0.45 $0.70 – $0.90 $1.20 – $1.50 +70% → +260% 1 day – 4 weeks Medium (40–50%) Real catalyst drop Short Squeeze + Gamma Ramp Un...
Read more